Internal Medicine, Pulmonary Disease · Chapel Hill, NC
NPI
1386656932
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
300 Meadowmont Village Cir Ste 203
Chapel Hill, NC, 27517
Phone (984) 974-5703
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
743 services
Medicare patients, 2024
260
Average age 71
Drug cost, 2024
$3.9M
1,417 prescriptions
Company payments, 2025
$54.83
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary L Daniels was code 94375 (pulmonary function testing), 116 times for 89 patients. In total Mary L Daniels billed 743 services in 31 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94375 Pulmonary Function Testing | Office | 116 | 89 | $9.74 | $1,130 |
| 99214 Office E&M - Established | Office | 111 | 87 | $66.12 | $7,339 |
| 99233 Hospital E&M - Subsequent | Facility | 84 | 39 | $87.61 | $7,359 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 75 | 65 | $11.66 | $874 |
| 99215 Office E&M - Established | Office | 75 | 51 | $103.63 | $7,772 |
| 99223 Hospital E&M - Initial | Facility | 36 | 35 | $125.03 | $4,501 |
| 94375 Pulmonary Function Testing | Facility | 32 | 31 | $9.98 | $319 |
| 94729 Pulmonary Function Testing | Office | 27 | 27 | $6.07 | $164 |
| 94729 Pulmonary Function Testing | Facility | 26 | 25 | $6.05 | $157 |
| 99291 Critical Care E&M | Facility | 22 | 14 | $157.73 | $3,470 |
| 94618 Pulmonary Function Testing | Office | 15 | 15 | $15.30 | $230 |
| 94060 Pulmonary Function Testing | Office | 14 | 14 | $6.49 | $90.84 |
By year: 2022 $44K for 815 services; 2023 $41K for 724 services; 2024 $38K for 743 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary L Daniels prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 129 prescriptions and refills. In total Mary L Daniels wrote 1,417 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 129 | 203 | 23 | $125K |
| Azithromycin Generic | 126 | 307 | 33 | $7,354 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 91 | 120 | 40 | $3,172 |
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 70 | 70 | Under 11 | $1.8M |
| Amikacin Sulfate Generic | 63 | 69 | Under 11 | $4,956 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 56 | 56 | Under 11 | $41K |
| Arikayce Amikacin Liposomal/Neb.Accessr | 54 | 54 | Under 11 | $801K |
| Prednisone Generic | 41 | 64 | 23 | $243 |
| Breo Ellipta Fluticasone/Vilanterol | 41 | 115 | 14 | $42K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 37 | 37 | 24 | $450 |
| Ipratropium Bromide Generic | 34 | 41 | Under 11 | $720 |
| Ventolin Hfa Albuterol Sulfate | 34 | 52 | Under 11 | $4,034 |
| Ethambutol Hcl Generic | 32 | 96 | Under 11 | $5,449 |
| Fluticasone Propionate Generic | 26 | 68 | Under 11 | $431 |
| Spiriva Respimat Tiotropium Bromide | 25 | 33 | Under 11 | $17K |
Brand drugs: - claims; generic drugs: 716 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary L Daniels $54.83 ($54.83 in general payments such as food, travel and fees) from 4 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $54.83.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $54.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.